CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Mathura Road, New Delhi, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Nucleic Acids Res. 2022 Jan 7;50(D1):D771-D776. doi: 10.1093/nar/gkab895.
Ever since the breakout of COVID-19 disease, ceaseless genomic research to inspect the epidemiology and evolution of the pathogen has been undertaken globally. Large scale viral genome sequencing and analysis have uncovered the functional impact of numerous genetic variants in disease pathogenesis and transmission. Emerging evidence of mutations in spike protein domains escaping antibody neutralization is reported. We have built a database with precise collation of manually curated variants in SARS-CoV-2 from literature with potential escape mechanisms from a range of neutralizing antibodies. This comprehensive repository encompasses a total of 5258 variants accounting for 2068 unique variants tested against 230 antibodies, patient convalescent plasma and vaccine breakthrough events. This resource enables the user to gain access to an extensive annotation of SARS-CoV-2 escape variants which would contribute to exploring and understanding the underlying mechanisms of immune response against the pathogen. The resource is available at http://clingen.igib.res.in/esc/.
自 COVID-19 疾病爆发以来,全球一直在进行不懈的基因组研究,以检查病原体的流行病学和进化。大规模的病毒基因组测序和分析揭示了许多遗传变异在疾病发病机制和传播中的功能影响。有报道称,刺突蛋白结构域的突变会逃避抗体中和。我们建立了一个数据库,其中精确地整理了来自文献中 SARS-CoV-2 的手动编辑变异体,这些变异体具有逃避一系列中和抗体的潜在机制。该综合资源共包含 5258 个变异体,涵盖了针对 230 种抗体、患者恢复期血浆和疫苗突破事件进行测试的 2068 个独特变异体。该资源使使用者能够访问 SARS-CoV-2 逃逸变异体的广泛注释,这将有助于探索和理解针对病原体的免疫反应的潜在机制。该资源可在 http://clingen.igib.res.in/esc/ 获得。